SPP1+ macrophages, characterized by co-expression of MERTK, promote fibrosis through Osteopontin deposition and aberrant repair processes, positioning SPP1 as a central mediator and potential therapeutic target in IPF (28). The gene discussed is SPP1; the disease is idiopathic pulmonary fibrosis.